MatsukiyoCocokara & Co. (MSMKF) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist MatsukiyoCocokara & Co. (MSMKF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 49/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026MatsukiyoCocokara & Co. (MSMKF) Gesundheitswesen & Pipeline-Uebersicht
MatsukiyoCocokara & Co. is a leading drug store and pharmacy chain in Japan, operating over 1,700 stores across 47 prefectures. With a focus on healthcare retail, the company leverages its extensive network and established brand to serve a broad customer base in the Japanese market.
Investmentthese
MatsukiyoCocokara & Co. presents a stable investment opportunity within the Japanese healthcare retail market. The company's established network of over 1,700 stores provides a strong foundation for consistent revenue generation. With a P/E ratio of 17.62 and a profit margin of 5.1%, the company demonstrates reasonable profitability. The dividend yield of 1.89% offers a steady income stream for investors. Growth catalysts include expanding product offerings and enhancing online presence. Potential risks include increasing competition from other drug store chains and evolving consumer preferences. The company's beta of -0.21 suggests low volatility compared to the broader market.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Operates 1,726 stores across 47 prefectures in Japan as of June 30, 2020, providing extensive market coverage.
- P/E ratio of 17.62 indicates a reasonable valuation compared to earnings.
- Profit margin of 5.1% reflects the company's ability to generate profits from its operations.
- Gross margin of 35.2% demonstrates effective cost management in product sales.
- Dividend yield of 1.89% offers a consistent income stream for investors.
Wettbewerber & Vergleichsunternehmen
Staerken
- Extensive store network across Japan.
- Established brand reputation.
- Wide range of products and services.
- Strong relationships with suppliers.
Schwaechen
- Reliance on the Japanese market.
- Exposure to regulatory changes in the healthcare industry.
- Competition from other drug store chains.
- Vulnerability to economic downturns.
Katalysatoren
- Upcoming: Expansion of online platform to increase reach and sales.
- Ongoing: Increasing private label product offerings to improve profitability.
- Ongoing: Strategic acquisitions to expand store network and market share.
- Ongoing: Focusing on preventative healthcare to capitalize on growing trend.
- Upcoming: Launch of new health and wellness product lines.
Risiken
- Ongoing: Increasing competition from other drug store chains.
- Potential: Changing consumer preferences and demand.
- Potential: Economic slowdown impacting consumer spending.
- Potential: Regulatory changes in the healthcare industry.
- Ongoing: Dependence on the Japanese market.
Wachstumschancen
- Expanding online presence: MatsukiyoCocokara & Co. can capitalize on the growing e-commerce trend by expanding its online platform and offering online ordering and delivery services. This would allow the company to reach a broader customer base and increase sales. The e-commerce market in Japan is expected to continue growing, providing a significant opportunity for MatsukiyoCocokara & Co. to increase its market share. Timeline: Ongoing.
- Increasing private label product offerings: MatsukiyoCocokara & Co. can increase its profitability by expanding its private label product offerings. Private label products typically have higher margins than branded products, allowing the company to improve its overall profitability. The market for private label products is growing in Japan, as consumers become more price-conscious. Timeline: Ongoing.
- Strategic acquisitions: MatsukiyoCocokara & Co. can pursue strategic acquisitions to expand its store network and market share. Acquiring smaller drug store chains or pharmacies would allow the company to quickly increase its presence in new markets and gain access to new customers. The Japanese drug store market is fragmented, providing opportunities for consolidation. Timeline: Ongoing.
- Focusing on preventative healthcare: MatsukiyoCocokara & Co. can capitalize on the growing trend of preventative healthcare by offering a wider range of preventative healthcare products and services. This could include vitamins, supplements, and health screenings. The market for preventative healthcare products and services is growing in Japan, as consumers become more health-conscious. Timeline: Ongoing.
- Expanding into new geographic markets: MatsukiyoCocokara & Co. can explore opportunities to expand into new geographic markets outside of Japan. This would allow the company to diversify its revenue streams and reduce its reliance on the Japanese market. The global healthcare retail market is growing, providing opportunities for MatsukiyoCocokara & Co. to expand its international presence. Timeline: Future
Chancen
- Expanding online presence.
- Increasing private label product offerings.
- Strategic acquisitions.
- Focusing on preventative healthcare.
Risiken
- Increasing competition.
- Changing consumer preferences.
- Economic slowdown.
- Regulatory changes.
Wettbewerbsvorteile
- Extensive store network across Japan provides a competitive advantage.
- Established brand reputation and customer loyalty.
- Strong relationships with pharmaceutical suppliers.
- Efficient supply chain and distribution network.
Ueber MSMKF
MatsukiyoCocokara & Co. was founded in 1932 and has grown to become a prominent drug store and pharmacy chain in Japan. The company operates a network of 1,726 stores as of June 30, 2020, spanning all 47 prefectures of Japan. These stores offer a wide range of products and services, including prescription drugs, over-the-counter medications, health and beauty products, and daily necessities. MatsukiyoCocokara & Co. aims to provide convenient access to healthcare and wellness products for its customers. The company has strategically expanded its store network and product offerings to meet the evolving needs of the Japanese market. MatsukiyoCocokara & Co. competes with other drug store chains and pharmacies in Japan, focusing on customer service, product selection, and store locations to maintain its competitive edge. The company is based in Matsudo, Japan, and continues to focus on strengthening its position in the Japanese healthcare retail sector.
Was das Unternehmen tut
- Operates a chain of drug stores and pharmacies.
- Sells prescription drugs.
- Offers over-the-counter medications.
- Provides health and beauty products.
- Sells daily necessities.
- Offers healthcare and wellness products.
Geschaeftsmodell
- Generates revenue through the sale of products in its stores.
- Prescription drug sales contribute a significant portion of revenue.
- Over-the-counter medications and health/beauty products also drive sales.
- The company leverages its store network to reach a broad customer base.
Branchenkontext
MatsukiyoCocokara & Co. operates within the competitive Japanese healthcare retail market. The industry is characterized by a large number of drug store chains and pharmacies, all vying for market share. Key trends include an aging population, increasing healthcare awareness, and growing demand for health and beauty products. The company competes with other major players such as CSMYF, KYKOF, RADLY, SHTDF, and SHTDY. MatsukiyoCocokara & Co. differentiates itself through its extensive store network, product selection, and customer service.
Wichtige Kunden
- Individual consumers seeking healthcare and wellness products.
- Patients requiring prescription medications.
- Customers looking for over-the-counter remedies.
- Individuals purchasing health and beauty products.
Finanzdaten
Chart & Info
MatsukiyoCocokara & Co. (MSMKF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer MSMKF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer MSMKF.
Kursziele
Wall-Street-Kurszielanalyse fuer MSMKF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von MSMKF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Kiyoo Matsumoto
CEO
Kiyoo Matsumoto serves as the CEO of MatsukiyoCocokara & Co., leading a workforce of 13,371 employees. His background includes extensive experience in the retail and healthcare sectors. He has held various leadership positions within the company, contributing to its growth and expansion. Matsumoto's expertise lies in strategic planning, operational efficiency, and customer relationship management. He is committed to driving innovation and enhancing the company's competitive position in the Japanese market. His leadership is focused on delivering value to shareholders and providing high-quality products and services to customers.
Erfolgsbilanz: Under Kiyoo Matsumoto's leadership, MatsukiyoCocokara & Co. has expanded its store network and enhanced its product offerings. He has overseen the implementation of key strategic initiatives aimed at improving operational efficiency and customer satisfaction. Matsumoto has also played a crucial role in fostering a culture of innovation and collaboration within the company. His leadership has contributed to the company's consistent financial performance and its strong position in the Japanese healthcare retail market.
MSMKF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that MatsukiyoCocokara & Co. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity compared to exchange-listed securities.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Wider bid-ask spreads increase transaction costs.
- Potential for fraud or manipulation is higher on the OTC market.
- OTC Other stocks may be subject to delisting or trading suspensions.
- Verify the company's registration and regulatory filings.
- Review the company's financial statements, if available.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any news or legal proceedings involving the company.
- Established history of operations in Japan since 1932.
- Extensive network of over 1,700 stores across Japan.
- Significant market capitalization of $7.23B.
- Positive profit margin of 5.1%.
- Payment of dividends with a yield of 1.89%.
MSMKF Healthcare Aktien-FAQ
What are the key factors to evaluate for MSMKF?
MatsukiyoCocokara & Co. (MSMKF) currently holds an AI score of 49/100, indicating low score. Key strength: Extensive store network across Japan.. Primary risk to monitor: Ongoing: Increasing competition from other drug store chains.. This is not financial advice.
How frequently does MSMKF data refresh on this page?
MSMKF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MSMKF's recent stock price performance?
Recent price movement in MatsukiyoCocokara & Co. (MSMKF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Extensive store network across Japan.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MSMKF overvalued or undervalued right now?
Determining whether MatsukiyoCocokara & Co. (MSMKF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MSMKF?
Before investing in MatsukiyoCocokara & Co. (MSMKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MSMKF to a portfolio?
Potential reasons to consider MatsukiyoCocokara & Co. (MSMKF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Extensive store network across Japan.. Additionally: Established brand reputation.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of MSMKF?
Yes, most major brokerages offer fractional shares of MatsukiyoCocokara & Co. (MSMKF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MSMKF's earnings and financial reports?
MatsukiyoCocokara & Co. (MSMKF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for MSMKF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on information available as of 2020 and may not reflect current performance.
- OTC market data may be limited and less reliable than exchange-listed data.
- AI analysis is pending and may provide further insights.